Synthesis of Polymer–Lipid Nanoparticles for Image-Guided Delivery of Dual Modality Therapy

For advanced treatment of diseases such as cancer, multicomponent, multifunctional nanoparticles hold great promise. In the current study we report the synthesis of a complex nanoparticle (NP) system with dual drug loading as well as diagnostic properties. To that aim we present a methodology where...

Full description

Bibliographic Details
Main Authors: Mieszawska, Aneta J, Kim, YongTae, Gianella, Anita, van Rooy, Inge, Priem, Bram, Labarre, Matthew P, Ozcan, Canturk, Cormode, David P, Petrov, Artiom, Langer, Robert, Farokhzad, Omid C, Fayad, Zahi A, Mulder, Willem JM
Other Authors: Koch Institute for Integrative Cancer Research at MIT
Format: Article
Language:English
Published: American Chemical Society (ACS) 2021
Online Access:https://hdl.handle.net/1721.1/134494
_version_ 1826201638734397440
author Mieszawska, Aneta J
Kim, YongTae
Gianella, Anita
van Rooy, Inge
Priem, Bram
Labarre, Matthew P
Ozcan, Canturk
Cormode, David P
Petrov, Artiom
Langer, Robert
Farokhzad, Omid C
Fayad, Zahi A
Mulder, Willem JM
author2 Koch Institute for Integrative Cancer Research at MIT
author_facet Koch Institute for Integrative Cancer Research at MIT
Mieszawska, Aneta J
Kim, YongTae
Gianella, Anita
van Rooy, Inge
Priem, Bram
Labarre, Matthew P
Ozcan, Canturk
Cormode, David P
Petrov, Artiom
Langer, Robert
Farokhzad, Omid C
Fayad, Zahi A
Mulder, Willem JM
author_sort Mieszawska, Aneta J
collection MIT
description For advanced treatment of diseases such as cancer, multicomponent, multifunctional nanoparticles hold great promise. In the current study we report the synthesis of a complex nanoparticle (NP) system with dual drug loading as well as diagnostic properties. To that aim we present a methodology where chemically modified poly(lactic-co-glycolic) acid (PLGA) polymer is formulated into a polymer-lipid NP that contains a cytotoxic drug doxorubicin (DOX) in the polymeric core and an anti-angiogenic drug sorafenib (SRF) in the lipidic corona. The NP core also contains gold nanocrystals (AuNCs) for imaging purposes and cyclodextrin molecules to maximize the DOX encapsulation in the NP core. In addition, a near-infrared (NIR) Cy7 dye was incorporated in the coating. To fabricate the NP we used a microfluidics-based technique that offers unique NP synthesis conditions, which allowed for encapsulation and fine-tuning of optimal ratios of all the NP components. NP phantoms could be visualized with computed tomography (CT) and near-infrared (NIR) fluorescence imaging. We observed timed release of the encapsulated drugs, with fast release of the corona drug SRF and delayed release of a core drug DOX. In tumor bearing mice intravenously administered NPs were found to accumulate at the tumor site by fluorescence imaging. © 2013 American Chemical Society.
first_indexed 2024-09-23T11:54:29Z
format Article
id mit-1721.1/134494
institution Massachusetts Institute of Technology
language English
last_indexed 2024-09-23T11:54:29Z
publishDate 2021
publisher American Chemical Society (ACS)
record_format dspace
spelling mit-1721.1/1344942023-03-01T15:28:59Z Synthesis of Polymer–Lipid Nanoparticles for Image-Guided Delivery of Dual Modality Therapy Mieszawska, Aneta J Kim, YongTae Gianella, Anita van Rooy, Inge Priem, Bram Labarre, Matthew P Ozcan, Canturk Cormode, David P Petrov, Artiom Langer, Robert Farokhzad, Omid C Fayad, Zahi A Mulder, Willem JM Koch Institute for Integrative Cancer Research at MIT Massachusetts Institute of Technology. Department of Chemical Engineering Harvard University--MIT Division of Health Sciences and Technology For advanced treatment of diseases such as cancer, multicomponent, multifunctional nanoparticles hold great promise. In the current study we report the synthesis of a complex nanoparticle (NP) system with dual drug loading as well as diagnostic properties. To that aim we present a methodology where chemically modified poly(lactic-co-glycolic) acid (PLGA) polymer is formulated into a polymer-lipid NP that contains a cytotoxic drug doxorubicin (DOX) in the polymeric core and an anti-angiogenic drug sorafenib (SRF) in the lipidic corona. The NP core also contains gold nanocrystals (AuNCs) for imaging purposes and cyclodextrin molecules to maximize the DOX encapsulation in the NP core. In addition, a near-infrared (NIR) Cy7 dye was incorporated in the coating. To fabricate the NP we used a microfluidics-based technique that offers unique NP synthesis conditions, which allowed for encapsulation and fine-tuning of optimal ratios of all the NP components. NP phantoms could be visualized with computed tomography (CT) and near-infrared (NIR) fluorescence imaging. We observed timed release of the encapsulated drugs, with fast release of the corona drug SRF and delayed release of a core drug DOX. In tumor bearing mice intravenously administered NPs were found to accumulate at the tumor site by fluorescence imaging. © 2013 American Chemical Society. 2021-10-27T20:05:16Z 2021-10-27T20:05:16Z 2013 2019-09-05T15:59:53Z Article http://purl.org/eprint/type/JournalArticle https://hdl.handle.net/1721.1/134494 Mieszawska, A. J., et al. "Synthesis of Polymer-Lipid Nanoparticles for Image-Guided Delivery of Dual Modality Therapy." Bioconjugate Chemistry 24 9 (2013): 1429-34. en 10.1021/BC400166J Bioconjugate Chemistry Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. application/pdf American Chemical Society (ACS) PMC
spellingShingle Mieszawska, Aneta J
Kim, YongTae
Gianella, Anita
van Rooy, Inge
Priem, Bram
Labarre, Matthew P
Ozcan, Canturk
Cormode, David P
Petrov, Artiom
Langer, Robert
Farokhzad, Omid C
Fayad, Zahi A
Mulder, Willem JM
Synthesis of Polymer–Lipid Nanoparticles for Image-Guided Delivery of Dual Modality Therapy
title Synthesis of Polymer–Lipid Nanoparticles for Image-Guided Delivery of Dual Modality Therapy
title_full Synthesis of Polymer–Lipid Nanoparticles for Image-Guided Delivery of Dual Modality Therapy
title_fullStr Synthesis of Polymer–Lipid Nanoparticles for Image-Guided Delivery of Dual Modality Therapy
title_full_unstemmed Synthesis of Polymer–Lipid Nanoparticles for Image-Guided Delivery of Dual Modality Therapy
title_short Synthesis of Polymer–Lipid Nanoparticles for Image-Guided Delivery of Dual Modality Therapy
title_sort synthesis of polymer lipid nanoparticles for image guided delivery of dual modality therapy
url https://hdl.handle.net/1721.1/134494
work_keys_str_mv AT mieszawskaanetaj synthesisofpolymerlipidnanoparticlesforimageguideddeliveryofdualmodalitytherapy
AT kimyongtae synthesisofpolymerlipidnanoparticlesforimageguideddeliveryofdualmodalitytherapy
AT gianellaanita synthesisofpolymerlipidnanoparticlesforimageguideddeliveryofdualmodalitytherapy
AT vanrooyinge synthesisofpolymerlipidnanoparticlesforimageguideddeliveryofdualmodalitytherapy
AT priembram synthesisofpolymerlipidnanoparticlesforimageguideddeliveryofdualmodalitytherapy
AT labarrematthewp synthesisofpolymerlipidnanoparticlesforimageguideddeliveryofdualmodalitytherapy
AT ozcancanturk synthesisofpolymerlipidnanoparticlesforimageguideddeliveryofdualmodalitytherapy
AT cormodedavidp synthesisofpolymerlipidnanoparticlesforimageguideddeliveryofdualmodalitytherapy
AT petrovartiom synthesisofpolymerlipidnanoparticlesforimageguideddeliveryofdualmodalitytherapy
AT langerrobert synthesisofpolymerlipidnanoparticlesforimageguideddeliveryofdualmodalitytherapy
AT farokhzadomidc synthesisofpolymerlipidnanoparticlesforimageguideddeliveryofdualmodalitytherapy
AT fayadzahia synthesisofpolymerlipidnanoparticlesforimageguideddeliveryofdualmodalitytherapy
AT mulderwillemjm synthesisofpolymerlipidnanoparticlesforimageguideddeliveryofdualmodalitytherapy